Market Cap 133.13B
Revenue (ttm) 402.07B
Net Income (ttm) 1.77B
EPS (ttm) N/A
PE Ratio 14.80
Forward PE 14.07
Profit Margin 0.44%
Debt to Equity Ratio 0.81
Volume 9,690,800
Avg Vol 8,634,482
Day's Range N/A - N/A
Shares Out 1.28B
Stochastic %K 78%
Beta 0.62
Analysts Strong Sell
Price Target $104.58

Company Profile

CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care manage...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 401 765 1500
Fax: 401 652 0893
Address:
One CVS Drive, Woonsocket, United States
EarlyT
EarlyT Jun. 26 at 8:15 PM
$CVS doing ok but Hum is on the move and not looking back
0 · Reply
Bugdug
Bugdug Jun. 26 at 6:46 PM
$CVS in this company lot of H1B managers working… Honestly US doesn’t need H1B managers for this kind of management roles…someone need to check deep inside company what is going on…
0 · Reply
lextrading
lextrading Jun. 26 at 5:08 PM
$UNH Approaching a key pivot and the weekly 200MA. $CVS has made a full recovery back to ATHs. It's prudent for me to stick with my plan and trim some gains at 450. Long since 250s.
0 · Reply
leifstocks
leifstocks Jun. 26 at 4:23 PM
$CVS 105 CALL 7/2 @ 1.35
0 · Reply
WallStJesus
WallStJesus Jun. 26 at 2:38 PM
$CVS REPEAT SWEEPER BUYING DETECTED
0 · Reply
DividendDaddyDK
DividendDaddyDK Jun. 26 at 12:10 PM
$CI $CNC $CVS $HUM $UNH Healthcare stocks own 2026 besides the crazy chip stocks.
0 · Reply
AdamBrennan2
AdamBrennan2 Jun. 26 at 10:23 AM
$CI is the cheapest out of the managed healthcare/insurance industry, crazy enough $UNH is starting to get more expensive since its been going up again $ELV $CVS $CNC
1 · Reply
parcha
parcha Jun. 26 at 3:16 AM
Friday's big stock stories: What’s likely to move the market in the next session $CVS CVS CNBC contributor and “Halftime Report” trader Josh Brown loves CVS. Thursday on “Halftime,” he called it “the best stock in the market.” The stock is up 45% in three months and it hit a new high on Thursday. The analysts are on his side: 25 have an overweight or buy rating, five deem it a hold, according to FactSet. The average price target is $104.25. Shares ended the session at $104.66. But Josh Brown said, “This is a big enough market cap for enough people to make money with.” https://www.cnbc.com/2026/06/25/fridays-big-stock-stories-whats-likely-to-move-the-market.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
Sportslome
Sportslome Jun. 25 at 7:22 PM
$CVS continuation tomorrow
0 · Reply
Small_time_trader
Small_time_trader Jun. 25 at 3:20 PM
$CVS raise you lt hand if you’re writing covered calls now
0 · Reply
Latest News on CVS
Florida  AG subpoenas CVS Health over reimbursement rates

2026-06-23T19:18:07.000Z - 5 days ago

Florida AG subpoenas CVS Health over reimbursement rates


CVS Health price target raised to $110 from $100 at BofA

2026-06-23T11:32:25.000Z - 5 days ago

CVS Health price target raised to $110 from $100 at BofA


CVS Health announces comprehensive approach to GLP-1 support

2026-06-22T12:14:51.000Z - 6 days ago

CVS Health announces comprehensive approach to GLP-1 support


CVS is Using Fluency to Close Enterprise AI Deployment Gap

Jun 11, 2026, 10:43 AM EDT - 17 days ago

CVS is Using Fluency to Close Enterprise AI Deployment Gap


CVS Health price target raised to $115 from $110 at Mizuho

2026-06-08T11:34:23.000Z - 20 days ago

CVS Health price target raised to $115 from $110 at Mizuho


CVS Health price target raised to $108 from $102 at Truist

2026-06-01T11:53:57.000Z - 27 days ago

CVS Health price target raised to $108 from $102 at Truist


H1 Receives $40M Investment in Round Led by CVS Health Ventures

May 28, 2026, 11:00 AM EDT - 4 weeks ago

H1 Receives $40M Investment in Round Led by CVS Health Ventures


ARCTRUST acquires seven property net lease portfolio

2026-05-28T12:44:58.000Z - 4 weeks ago

ARCTRUST acquires seven property net lease portfolio

GPC PNFP


CVS brings back coverage for Lilly's obesity drug Zepbound

May 28, 2026, 6:47 AM EDT - 4 weeks ago

CVS brings back coverage for Lilly's obesity drug Zepbound

LLY


CVS Health price target raised to $106 from $101 at Barclays

2026-05-26T14:20:04.000Z - 4 weeks ago

CVS Health price target raised to $106 from $101 at Barclays


Glenview Capital issues statement on CVS Health position

2026-05-21T20:24:11.000Z - 5 weeks ago

Glenview Capital issues statement on CVS Health position


Glenview Capital Issues Statement on CVS Health

May 21, 2026, 4:15 PM EDT - 5 weeks ago

Glenview Capital Issues Statement on CVS Health


The Big 3: NKE, CVS, CSCO

May 20, 2026, 1:00 PM EDT - 5 weeks ago

The Big 3: NKE, CVS, CSCO

CSCO NKE


CVS Health price target raised to $110 from $102 at Mizuho

2026-05-20T10:45:36.000Z - 5 weeks ago

CVS Health price target raised to $110 from $102 at Mizuho


CVS Health Transcript: AGM 2026

May 14, 2026, 8:00 AM EDT - 6 weeks ago

CVS Health Transcript: AGM 2026


CVS unit Omnicare wins court approval for sale to GenieRx

May 13, 2026, 4:26 PM EDT - 6 weeks ago

CVS unit Omnicare wins court approval for sale to GenieRx


CVS Health Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

CVS Health Earnings Call Transcript: Q1 2026


CVS Health Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

CVS Health Earnings release: Q1 2026


CVS Health Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

CVS Health Quarterly report: Q1 2026


CVS Health Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

CVS Health Slides: Q1 2026


CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 7 weeks ago

CVS to drop J&J's Stelara from its main formularies

JNJ


How CVS Uses Robots to Keep Your Deodorant in Stock

May 1, 2026, 5:30 AM EDT - 2 months ago

How CVS Uses Robots to Keep Your Deodorant in Stock


The Big 3: COST, CVS & MPC

Apr 30, 2026, 1:30 PM EDT - 2 months ago

The Big 3: COST, CVS & MPC

COST MPC


U.S. Health Insurers Step Up Prior Authorization Reforms

Apr 24, 2026, 8:20 AM EDT - 2 months ago

U.S. Health Insurers Step Up Prior Authorization Reforms

UNH


CVS distribution center workers plan to go on strike

Apr 16, 2026, 12:04 PM EDT - 2 months ago

CVS distribution center workers plan to go on strike


EarlyT
EarlyT Jun. 26 at 8:15 PM
$CVS doing ok but Hum is on the move and not looking back
0 · Reply
Bugdug
Bugdug Jun. 26 at 6:46 PM
$CVS in this company lot of H1B managers working… Honestly US doesn’t need H1B managers for this kind of management roles…someone need to check deep inside company what is going on…
0 · Reply
lextrading
lextrading Jun. 26 at 5:08 PM
$UNH Approaching a key pivot and the weekly 200MA. $CVS has made a full recovery back to ATHs. It's prudent for me to stick with my plan and trim some gains at 450. Long since 250s.
0 · Reply
leifstocks
leifstocks Jun. 26 at 4:23 PM
$CVS 105 CALL 7/2 @ 1.35
0 · Reply
WallStJesus
WallStJesus Jun. 26 at 2:38 PM
$CVS REPEAT SWEEPER BUYING DETECTED
0 · Reply
DividendDaddyDK
DividendDaddyDK Jun. 26 at 12:10 PM
$CI $CNC $CVS $HUM $UNH Healthcare stocks own 2026 besides the crazy chip stocks.
0 · Reply
AdamBrennan2
AdamBrennan2 Jun. 26 at 10:23 AM
$CI is the cheapest out of the managed healthcare/insurance industry, crazy enough $UNH is starting to get more expensive since its been going up again $ELV $CVS $CNC
1 · Reply
parcha
parcha Jun. 26 at 3:16 AM
Friday's big stock stories: What’s likely to move the market in the next session $CVS CVS CNBC contributor and “Halftime Report” trader Josh Brown loves CVS. Thursday on “Halftime,” he called it “the best stock in the market.” The stock is up 45% in three months and it hit a new high on Thursday. The analysts are on his side: 25 have an overweight or buy rating, five deem it a hold, according to FactSet. The average price target is $104.25. Shares ended the session at $104.66. But Josh Brown said, “This is a big enough market cap for enough people to make money with.” https://www.cnbc.com/2026/06/25/fridays-big-stock-stories-whats-likely-to-move-the-market.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
Sportslome
Sportslome Jun. 25 at 7:22 PM
$CVS continuation tomorrow
0 · Reply
Small_time_trader
Small_time_trader Jun. 25 at 3:20 PM
$CVS raise you lt hand if you’re writing covered calls now
0 · Reply
reversefunnelsystem
reversefunnelsystem Jun. 25 at 2:47 PM
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 25 at 3:19 AM
$CVS Current Stock Price: $101.97 Contracts to trade: $102.0 CVS Jun 26 2026 Call Entry: $0.97 Exit: $1.92 ROI: 98% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MarketCommanderr
MarketCommanderr Jun. 24 at 10:51 PM
$CVS pushed to a fresh 52-week high after a 4.7% move, standing out in a tape where volume was relatively light. The stock continues to grind higher over both monthly and yearly timeframes, showing steady accumulation rather than a single-event spike. Even with the outsized move, price action suggests a controlled trend rather than a blow-off.
0 · Reply
MorganHoratio
MorganHoratio Jun. 24 at 7:17 PM
Healthcare | $IHF $HIMS $UNH $CVS The healthcare provider ETF $IHF is materializing as a premier "dual-track alpha" armor as macro de-risking accelerates! The structural convergence of legacy managed care and high-margin digital health is creating phenomenal entry windows. Telehealth disruptor $HIMS is undergoing massive institutional accumulation above key Fibonacci volume floors. By aggressively shifting away from controversial peptide compounding and signing an elite official distribution partnership with Novo Nordisk for branded Wegovy/Ozempic, HIMS has completely neutralized its regulatory bear case to unlock hyper-growth. Insurer anchor $UNH has aggressively stabilized following its successful FTC insulin pricing settlement and target upgrades, while retail pharmacy giant $CVS surges heavily after launching dedicated virtual GLP-1 consultation services. Are you riding the massive consumer tailwinds of $HIMS, or capturing the deep defensive value of $UNH / $CVS on local technical dips?
0 · Reply
TheLocoPro
TheLocoPro Jun. 24 at 3:06 PM
$BLIN “Bridgeline powers digital experiences for some of the world’s largest brands including $CAT ($453B MC) $CVS ($130B MC), $SHEL ($222B MC), $UPS ($90B MC), 7 Eleven (As of August 2024, 7-Eleven operates roughly 85,000 stores worldwide) and more.” Holy cow this is going to explode once people find it
0 · Reply
newtwo99
newtwo99 Jun. 24 at 1:59 PM
$CI $CNC $CVS $HUM $UNH could result in some recoupment!
0 · Reply
roejohn
roejohn Jun. 24 at 9:32 AM
$CVS poorly run company ! Belongs at .50
1 · Reply
roejohn
roejohn Jun. 24 at 9:24 AM
$CVS RDY has the approval for generic approval of ozempic . Also, IMMERSE is equivalent to 3 eggs and 2.5 cups of milk ! CVS needs to reduce cost and get healthy products in their pharmacies .. promote SENS , not just vaccines ! CVS is passe
0 · Reply
nibbs343
nibbs343 Jun. 23 at 9:03 PM
$CVS subpoenaed lol time to crater
0 · Reply
peloswing
peloswing Jun. 23 at 4:21 PM
$CVS is up 8% Since this Flow Post! Trump's calls are now $1.7 ITM
0 · Reply
GREEENPANDA
GREEENPANDA Jun. 23 at 3:46 PM
$CVS $NKE brand was strong 15 years ago. Ceo and brand no bueno
1 · Reply
DividendDaddyDK
DividendDaddyDK Jun. 23 at 3:42 PM
$CI $CNC $CVS $HUM $UNH This sounds more like a crackdown on individual fraud schemes and healthcare operators than on the insurers themselves. The headline mentions the sector, but so far it looks like the DOJ is targeting alleged fraudsters across the healthcare system, not accusing UNH or the other major insurers of wrongdoing.
0 · Reply